TUMIR: an experimentally supported database of microRNA deregulation in various cancers by Lei Dong et al.
JOURNAL OF 
CLINICAL BIOINFORMATICS
Dong et al. Journal of Clinical Bioinformatics 2013, 3:7
http://www.jclinbioinformatics.com/content/3/1/7DATABASE Open AccessTUMIR: an experimentally supported database of
microRNA deregulation in various cancers
Lei Dong1, Min Luo1, Fang Wang1, Junwu Zhang1, Tingting Li2 and Jia Yu1*Abstract
Background: MicroRNAs were found to play an important role in cancers and several literatures exist to describe
the relationship between microRNA and cancer, but the expression pattern was still faintly. There is a need for a
comprehensive collection and summary of the interactions under experimental support.
Description: TUMIR (http://www.ncrnalab.com/TUMIR/), a manually extracted database of experimentally supported
microRNA-cancer relationship, aims at providing a large, high-quality, validated comprehensive resource of
microRNA deregulation in various cancers. The current version includes a systematic literature search to May-1-2012
using PubMed database, contains data extracted from 205 literatures and 1163 entries describing a regulatory
interaction between human microRNAs and cancers. Each entry in the database contains the details of microRNA
name, the disease name, case number, control number, p value, the experimentally validated targets, sample type,
and a brief description of patients’ clinic pathologic parameters mentioned in the same paper. The website has
several extensive external links to the related websites and any requests can be made by emailing to
tumir_pumc@163.com.
Conclusion: TUMIR is an open access website and will be an accurate clue for the researchers who are interested
in better understanding the relationship between miRNAs and cancer.
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MicroRNAs (miRNAs) are a class of approximately 22–25
nt long endogenous single-stranded RNAs that generally
repress the expression of mRNAs. They control mRNA
degradation and/or translation through employing a silen-
cing complex to target the 3' UTR region of the mRNAs
[1]. In the past decades, miRNAs were found to play an
important role in a wide range of biological processes and
human diseases especially in tumors [2-4].
Since hundreds of miRNAs were predicted and identified
in human cells and tissues, a lot of miRNA-related data-
bases have been built. Of them, several resources provide
complete annotation and nomenclature such as miRBase
[5], miRGator [6] and miRGen [7]. Several provide experi-
mentally validated microRNA information such as TarBase* Correspondence: j-yu@ibms.pumc.edu.cn
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reproduction in any medium, provided the or[8], miR2Disease [9], dbDEMC [10], miRCancer [11] and
miRecords [12]; And also several provide computational
predictions such as TargetScan [13], PicTar [14] and
microRNA.org [15]. TUMIR is mainly focusing on the data
with experimental validation and all samples mentioned in
this database must be collected from human. In contrast to
TUMIR, the dbDEMC [10] retrieved miRNA-cancer rela-
tionship mainly from the analysis of high-throughput ex-
pression data. miR2Disease [9], the same as miRCancer
[11], integrated data from various experiments without
distinguishing human samples from cell lines. Meanwhile,
TUMIR is also different from TarBase [8] and miRecords
[12] which mainly focused on the miRNA targets. In a
word, TUMIR provides a soild evidence of the miRNA de-
regulation in various cancers.
Accumulating evidence is emerging that miRNAs are
closely involved in human cancer initiation, progression,
prognosis and diagnosis. Moreover, some miRNAs have
been shown to dysregulate and function as tumor suppres-
sors or oncogenes in many kinds of cancers. For example,
miR-21 is frequently upregulated in human hepatocellulartd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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regulated in acute myeloid leukemia [19], and liver cancer
[20]. Actually, many groups conducted the same experi-
mental designation to analyze miRNA expression through
miRNA array, real-time PCR, northern blot or other
methods in human tissues or cells. However, the accuracy
of miRNA expression might be interfered by different ma-
terials and methods used in these experiments, For ex-
ample, miR-21, which has been recognized as an oncomir
in most of cancers, did not show any differences between
case and control groups in some experiments [21]; miR-
375, which was found to be down-regulated in multiple
cancers, was shown to be up-regulated in some cancers
[22-24]. Therefore, finding a clear expression pattern in
certain cancer remains a challenging task, especially a sys-
tematic documentation and analysis of such experimentally
supported miRNA-cancer relationship is needed. To this
aim, we have developed a manually extracted database:
TUMIR, which provides a large, high-quality, and experi-
mentally validated comprehensive resource of miRNA de-
regulation in various cancers.
The TUMIR database contains the relationship be-
tween miRNAs and cancer, together with the parameters
of the design of experiments and patients’ clinic patholo-
gies. Additionally, the website has several extensive links,
such as a direct link to the paper’s information from the
NCBI [25] website or a hyper link to the miRNA’s infor-
mation from miRBase [5].Construction and content
Data sources
We conducted a systematic literature search to May-1-2012
using PubMed database, by means of the terms: “cancer”,
“carcinoma” and “neoplasm” in combination with the key-
words “microRNA” and “miRNA”. All results were limited
to studies of human. We also searched the reference lists of
eligible studies and relevant reviews. Reports fulfilling the
following criteria were included if: (i) they were miRNA
profiling studies in patients with cancer; (ii) they used can-
cer and noncancerous samples for comparison; (iii) they did
not only use high-throughput methods; (iv) there are more
than three samples in the studies and when they got the ex-
pression values, the samples could not be pooled. Thus,
miRNA profiling studies using only cell lines, or only focus-
ing on the utilization of microarrays, sequencing methods
were not included.Implementation
All the data were stored in a series of relational database
implemented with MySQL 5.5.0 on windows system.
The front-end web interface implementation is based on
PHP and Javascript running under Apache 2.2.21. APIs
were generated by java version 1.7.0_15.The current release of TUMIR contains data extracted
from 205 literatures and 1163 entries describing regulatory
interactions between human miRNAs and cancer, and
complete citations are also provided. The TUMIR data set
contains the expression pattern of miRNAs that were up-
regulated, down-regulated or no significant changes in
various cancers. Each entry in the database contains the
details of miRNA name, the disease name, case number,
control number, p value, the experimentally validated tar-
gets, sample type (tissue, serum, etc.) and a brief descrip-
tion of patients’ clinicopathologic parameters mentioned in
the same paper. TUMIR provides a user-friendly interface
for searching each entry by miRNA name or cancer name.
Utility and discussion
Search page
The TUMIR is designed to serve as a search engine to
query of confirmed miRNA-cancer relationship with ex-
perimental support. It provides a drop-down list search
function. Users can query the database by choosing a
miRNA name or cancer type. Once a certain miRNA or
cancer type is received as a key word, the search engine will
search all the items that contain the query word in TUMIR
database. For instance, hsa-miR-375 was reported in a lot of
original publications and it was hard to make a full under-
standing of its expression pattern in various cancer. When
users plan to query the expression pattern in all kinds of
cancer, they can choose the key word “hsa-miR-375” from
the “Search by miRNA Name” drop-down list and retrieve
all the systematic documentation of the selected miRNA.
After that, a“search results" web page emerges and shows
all of information involved in “hsa-miR-375” from queried
cancer papers. Each paper is introduced as an individual
table, which includes multiple items representing differently
experimental data. In the "search results" page, users are
able to freely choose the items they are interested in by
marking the checked box before the detailed information.
They also can click "CHECK_ALL" button located at the
top or bottom of the tables to select all of items listed in
these tables, or click "CANCEL" button to quit all of selec-
tions. However, users have to select at least one item before
they press "Submit" button to access the next step. In
addition, clicking the "reference" button under the hyperlink
of title will lead to the full reference information of the
paper (author, date, magazine, etc.). In this page, clicking
the "Submit" button will show the summary information of
the items you chose. Different expression patterns of
miRNAs in cancer are separated by colors. Users will find
the relationship between this miRNA and certain cancer by
clicking the hyperlinks at the top of tables directly.
Similar to search by miRNA name, users can choose
certain cancer from the “Search by Cancer Type” drop-
down list, such as “gastric” cancer. Users can also choose
their interested items in the "search results" page and click
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ent from searching by miRNA name, the data here is orga-
nized by selected cancer and different miRNAs (Figure 1).
Statistics page
The statistics page currently demonstrates 4 histograms
of the number of miRNAs and samples associated with
multiple cancers archived in TUMIR. These histograms
summarized the status of miRNA-cancer researches.
Help page
We employed a user case and a user guide here to make
researchers better understand the usability of our website.
TUMIR also offers a submission part in this page that al-
lows other researchers to submit un-documented miRNA-
cancer patterns. Once accepted by the submission checkup
team, the submitted resources will be updated into the
database, and will be available to the public in the next
release. TUMIR will be updated bimonthly.
Download page
All of the data described above is freely available for
download in TUMIR according to the GNU Public Li-
cense. Users who want to download the current release or
previous versions of TUMIR will be taken to the “down-
load” page by clicking “Download” button from the top
menu bar. These data are available in multiple formats,
such as .sql, .xls and a tab-delimited format. We alsoFigure 1 A schematic workflow of TUMIR.provide a series of APIs here for batch search, researches
can download the APIs, javadocs and a test program here.Conclusions
The current version of TUMIR attempted to build a widely
accessible and user-friendly database that connects
miRNAs with cancer through their experimentally sup-
ported expression patterns. Although the precise molecular
mechanism surrounding many miRNAs and cancer re-
quires further clarification, TUMIR can provide us accurate
clue to better descript the relationship between miRNAs
and cancer. In order to provide a central resource for the
doctors who wish to find some diagnostic markers of cer-
tain cancer or for the researchers who wish to study the
function and molecular mechanism of miRNAs in some
cancer, we not only continuously expand the numbers of
known and newly identified items but also create more ex-
ternal links to related websites. We also allow other re-
searchers to contribute to the data contents. Recently, long
non-coding RNAs (lncRNAs) in mammals were found to
be powerful regulators of gene expression in normal and
pathological conditions [26-29]. Similar to miRNAs,
lncRNAs have been shown to play vital roles in cancer, and
their expression and function are largely unknown [26]. In
order to satisfy these requirements, we plan to make rap-
idly updates and modifications to present a new version
of TUMIR.
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Availability
The TUMIR database can be directly accessed from
the web page: http://www.ncrnalab.com/TUMIR/. This
database is publicly and freely accessible, requiring no
registration and with no restrictions on use.
Technical requirements
It is recommended that one of the following browsers is
used: Mozilla Firefox 3 or Safari 4 on Linux, Mac OSX
or Windows, Chrome on Linux or Windows, Internet
Explorer 8 on Windows. In order to use the APIs, the
java complier compliance level should be 1.7.
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